Related Experiment Videos

"Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism

Hitoshi Shiota1, Janine E Elya1, Artyom A Alekseyenko2,3

  • 1Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Insights

Researchers discovered a new fusion partner, ZNF592, for the NUT gene in Nuclear protein in testis (NUT) carcinoma. This finding highlights the oncogenic role of Z4 factors, offering potential new therapeutic targets for this aggressive cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Nuclear protein in testis (NUT) carcinoma (NC) is a rare, aggressive squamous carcinoma.
  • NC is characterized by NUT-fusion oncogenes, most commonly BRD4-NUT, resulting from chromosomal translocations.

Purpose of the Study:

  • To identify novel NUT fusion partners in NC.
  • To investigate the role of Z4 complex proteins in NC pathogenesis.
  • To explore Z4 factors as potential therapeutic targets.

Main Methods:

  • Next-generation sequencing and Fluorescence In Situ Hybridization (FISH) were used to identify gene fusions.
  • Immunofluorescence microscopy was employed to study protein localization.
  • Ectopic expression studies were performed in cell lines.

Main Results:

  • A novel NUT fusion involving ZNF592 was identified in a patient with NC.
  • Wild-type ZNF592 and other Z4 complex proteins (ZNF532, ZMYND8) colocalize with BRD4-NUT in nuclear foci.
  • Ectopic BRD4-NUT expression induced Z4 factor sequestration.
  • NC cells demonstrated a specific dependency on ZNF532 and ZNF592.

Conclusions:

  • ZNF592 is a novel oncogenic fusion partner for NUT in NC.
  • Z4 factors play a critical oncogenic role in NC.
  • Targeting Z4 factors presents a potential therapeutic strategy for NC.

Related Concept Videos